文献支持
Coronavirus spike重组蛋白|Recombin
ant SARS-CoV-2 B.1.1.529 (Omicron) S1+S2 trimer Protein ( ECD, His Tag)- ￥5820
- Sino Biological
- 北京
- 40589-V08H26
- 2025年08月12日
企业认证
相关产品推荐更多 >
重组甲型流感 H1N1 Hemagglutinin/HA蛋白(ECD,His Tag)
询价
Influenza A H7N9 (A/Shanghai/1/2013) Hemagglutinin / HA Protein (HA1+HA2, cleavage) (His Tag)
￥4520
Coronavirus spike重组蛋白|Recombinant SARS-CoV-2 Spike RBD-His Recombinant Protein
￥4520
新型冠状病毒S蛋白|2019-nCoV Spike重组蛋白|SARS-COV-2 S protein
￥4500
重组甲型流感病毒Hemagglutinin/HA蛋白
￥4520
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20℃ to -80℃
- 保质期：
12个月
- 英文名：
Recombinant SARS-CoV-2 B.1.1.529 (Omicron) S1+S2 trimer Protein ( ECD, His Tag)
- 库存：
99
- 供应商：
北京义翘神州科技股份有限公司
- 规格：
100.00 µg
重组新冠病毒 B.1.1.529 (Omicron) S1+S2 trimer 蛋白 ( ECD, His标签)（产品说明）
蛋白名称：SARS-CoV-2 B.1.1.529 (Omicron) S1+S2 trimer Protein ( ECD, His Tag)
蛋白构建：A DNA sequence encoding the SARS-CoV-2 Spike S1+S2 (YP_009724390.1, with mutations A67V, HV69-70 deletion, T95I, G142D, VYY143-145 deletion, N211 deletion, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, F817P, N856K, A892P, A899P, A942P, Q954H, N969K, L981F, K986P, V987P and furin cleavage site mutants) expressed with the bacteriophage T4 fibritin and a polyhistidine tag at the C-terminus. The mutations were identified in the SARS-CoV-2 variant (known as variant B.1.1.529) which emerged in the South Africa.
表达宿主：HEK293 Cells
蛋白纯度：> 90 % as determined by SDS-PAGE. > 95 % as determined by SEC-HPLC.
蛋白活性：Immobilized human ACE2 protein (mFc tag)(Cat:10108-H05H) at 2 μg/mL (100 μL/well) can bind SARS-CoV-2 B.1.1.529 (Omicron) S1+S2 trimer Protein ( ECD, His Tag)(Cat:40589-V08H26), the EC50 is 4-15 ng/mL.
蛋白内毒素：< 1.0 EU per μg protein as determined by the LAL method.
预测N端：Val 16
蛋白分子量：The recombinant SARS-CoV-2 Spike S1+S2 consists of 1228 amino acids and predicts a molecular mass of 136.67 kDa.
蛋白NP号：YP_009724390.1
蛋白氨基酸序列：0
蛋白标签：C-His
蛋白保存条件：Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
蛋白名称：SARS-CoV-2 B.1.1.529 (Omicron) S1+S2 trimer Protein ( ECD, His Tag)
蛋白构建：A DNA sequence encoding the SARS-CoV-2 Spike S1+S2 (YP_009724390.1, with mutations A67V, HV69-70 deletion, T95I, G142D, VYY143-145 deletion, N211 deletion, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, F817P, N856K, A892P, A899P, A942P, Q954H, N969K, L981F, K986P, V987P and furin cleavage site mutants) expressed with the bacteriophage T4 fibritin and a polyhistidine tag at the C-terminus. The mutations were identified in the SARS-CoV-2 variant (known as variant B.1.1.529) which emerged in the South Africa.
表达宿主：HEK293 Cells
蛋白纯度：> 90 % as determined by SDS-PAGE. > 95 % as determined by SEC-HPLC.
蛋白活性：Immobilized human ACE2 protein (mFc tag)(Cat:10108-H05H) at 2 μg/mL (100 μL/well) can bind SARS-CoV-2 B.1.1.529 (Omicron) S1+S2 trimer Protein ( ECD, His Tag)(Cat:40589-V08H26), the EC50 is 4-15 ng/mL.
蛋白内毒素：< 1.0 EU per μg protein as determined by the LAL method.
预测N端：Val 16
蛋白分子量：The recombinant SARS-CoV-2 Spike S1+S2 consists of 1228 amino acids and predicts a molecular mass of 136.67 kDa.
蛋白NP号：YP_009724390.1
蛋白氨基酸序列：0
蛋白标签：C-His
蛋白保存条件：Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
1, Wang S, et al. Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron.Cell reports, PubMed ID: 35594869
2, Xu Y, et al. Structural and biochemical mechanism for increased infectivity and immune evasion of Omicron BA.2 variant compared to BA.1 and their possible mouse origins.Cell research, PubMed ID: 35641567
3, Du P, et al. A bivalent vaccine containing D614G and BA.1 spike trimer proteins or a BA.1 spike trimer protein booster shows broad neutralizing immunity.Journal of medical virology, PubMed ID: 35614524
4, Li H, et al. Isolation of a human SARS-CoV-2 neutralizing antibody from a synthetic phage library and its conversion to fluorescent biosensors.Scientific reports, PubMed ID: 36109569
5, Wu Y, et al. Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine.Cell host & microbe, PubMed ID: 36323313
6, Wussow F, et al. Synthetic multiantigen MVA vaccine COH04S1 and variant-specific derivatives protect Syrian hamsters from SARS-CoV-2 Omicron subvariants.NPJ vaccines, PubMed ID: 36928589
7, Hernandez NE, et al. Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus.Heliyon, PubMed ID: 37035348
8, Hornsby H, et al. Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history.Nature communications, PubMed ID: 37604803
9, Chen J, et al. Magnetic-responsive upconversion luminescence resonance energy transfer (LRET) biosensor for ultrasensitive detection of SARS-CoV-2 spike protein.Biosensors & bioelectronics, PubMed ID: 38154329
10, Sui Y, et al. Adjuvanted subunit intranasal vaccine prevents SARS-CoV-2 onward transmission in hamsters.bioRxiv : the preprint server for biology, PubMed ID: 38798555
11, Sibille G, et al. The Novel A-Type Proanthocyanidin-Rich Phytocomplex SP4™ Acts as a Broad-Spectrum Antiviral Agent against Human Respiratory Viruses.International journal of molecular sciences, PubMed ID: 39000477
12, Guenthoer J, et al. The S2 subunit of spike encodes diverse targets for functional antibody responses to SARS-CoV-2.PLoS pathogens, PubMed ID: 39093891
2, Xu Y, et al. Structural and biochemical mechanism for increased infectivity and immune evasion of Omicron BA.2 variant compared to BA.1 and their possible mouse origins.Cell research, PubMed ID: 35641567
3, Du P, et al. A bivalent vaccine containing D614G and BA.1 spike trimer proteins or a BA.1 spike trimer protein booster shows broad neutralizing immunity.Journal of medical virology, PubMed ID: 35614524
4, Li H, et al. Isolation of a human SARS-CoV-2 neutralizing antibody from a synthetic phage library and its conversion to fluorescent biosensors.Scientific reports, PubMed ID: 36109569
5, Wu Y, et al. Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine.Cell host & microbe, PubMed ID: 36323313
6, Wussow F, et al. Synthetic multiantigen MVA vaccine COH04S1 and variant-specific derivatives protect Syrian hamsters from SARS-CoV-2 Omicron subvariants.NPJ vaccines, PubMed ID: 36928589
7, Hernandez NE, et al. Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus.Heliyon, PubMed ID: 37035348
8, Hornsby H, et al. Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history.Nature communications, PubMed ID: 37604803
9, Chen J, et al. Magnetic-responsive upconversion luminescence resonance energy transfer (LRET) biosensor for ultrasensitive detection of SARS-CoV-2 spike protein.Biosensors & bioelectronics, PubMed ID: 38154329
10, Sui Y, et al. Adjuvanted subunit intranasal vaccine prevents SARS-CoV-2 onward transmission in hamsters.bioRxiv : the preprint server for biology, PubMed ID: 38798555
11, Sibille G, et al. The Novel A-Type Proanthocyanidin-Rich Phytocomplex SP4™ Acts as a Broad-Spectrum Antiviral Agent against Human Respiratory Viruses.International journal of molecular sciences, PubMed ID: 39000477
12, Guenthoer J, et al. The S2 subunit of spike encodes diverse targets for functional antibody responses to SARS-CoV-2.PLoS pathogens, PubMed ID: 39093891
技术资料暂无技术资料 索取技术资料
文献支持
Coronavirus spike重组蛋白|Recombinant SARS-CoV-2 B.1.1.529 (Omicron) S1+S2 trimer Protein ( ECD, His Tag)
￥5820
